Keyphrases:

BIG_TOKEN__¡¬512_patent__BIG_TOKEN
perfusion
BIG_TOKEN__¡¬561_patent__BIG_TOKEN
docetaxel
ethanol
¡¬561
taxanes
anaphylactic
hydroxy
Aventis_Pharma_S.A.
====================================
top sentences:

BIG_TOKEN__¡¬561_patent__BIG_TOKEN col.1 ll.59-63 ; BIG_TOKEN__¡¬512_patent__BIG_TOKEN col.2 ll.31-35 .
17.642231
5,750,561 ( `` BIG_TOKEN__¡¬561_patent__BIG_TOKEN `` ) and 5,714,512 ( `` BIG_TOKEN__¡¬512_patent__BIG_TOKEN `` ) .
11.057679
The BIG_TOKEN__¡¬512_patent__BIG_TOKEN is titled `` New compositions containing taxane_derivatives , '' and discloses taxane_compositions with reduced ethanol .
8.205430
The ¡¬561 and BIG_TOKEN__¡¬512_patent__BIG_TOKEN s relate to using surfactants other than Cremophor with docetaxel and decreasing the amount of ethanol to reduce alcohol_intoxication and anaphylactic_effects in patients .
7.696638
The BIG_TOKEN__¡¬561_patent__BIG_TOKEN is titled `` Compositions containing taxane_derivatives '' and describes taxane_compositions , including a perfusion that avoids anaphylactic and alcohol_intoxication_manifestations .
7.568800
